KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 ...

KeyBanc initiated coverage of BKV Corp. (BKV) with an Overweight rating and $23 price target BKV is primarily a natural gas-focused ...

Citi analyst Scott Gruber initiated coverage of BKV Corp. (BKV) with a Buy rating and $29 price target BKV stands apart from the exploration ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

I write articles about Thailand's financial markets and economy. Shares of BKV Corp—a unit of Thailand’s billionaire Vongkusolkit family-led Banpu—closed flat in its trading debut on ...

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV”) (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share.

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 billion. The beginning of the U ...

Sept 25 (Reuters) - Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering. The company priced its offering of 15 million shares at $18 ...

BKV is the US-based gas-producing unit of Thailand's Banpu Pcl, and largest natural gas producer in the Barnett Shale. BKV Corp made its public trading debut with its shares priced below range but ...

Sept 26 (Reuters) - Shares of BKV (BKV.N), opens new tab rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 ...

Obesity-drug developer BioAge holds on to a slim gain, while Texas-based Barnett Shale driller BKV trades flat Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell ...